SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Mahalia Jackson

PatientMahalia Jackson
Date of birth1973-10-26
IdentifiersMRN HR-ML035-SYN; SSN (made up) 000-35-4692
Document date2026-02-23
AuthorBeatrice Fontenot, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

EBUS result and pulmonology consultation. [S]

History of Present Illness

Ms. Jackson returns two weeks after her first visit. The CT of the chest two days after that visit showed enlarged hilar and mediastinal lymph nodes and small nodules along the airways in both upper lobes. EBUS-guided needle aspiration five days ago found non-necrotizing granulomas in three lymph node stations, with negative stains for mycobacteria and fungi; cultures are growing nothing so far. The interferon-gamma release assay and HIV test from the first visit were negative. She stopped the over-the-counter calcium and vitamin D tablets as advised. Her breathlessness and cough are unchanged, and she had one more spell of palpitations while singing at church. She has postponed her concerts for the next three weeks. Dr. Asante-Miller saw her this morning, and she had full lung function tests. She has had no thoughts of self-harm. [S]

ElementDetail
TissueNon-necrotizing granulomas at stations 4R, 7 and 11L; stains negative; cultures pending; lavage lymphocytes 32 percent, CD4 to CD8 ratio 5.2
Infection excluded so farInterferon-gamma release assay and HIV negative; acid-fast and fungal stains negative
Lung functionFVC 74 percent and DLCO 62 percent of predicted
SymptomsBreathlessness and cough unchanged; one more spell of palpitations
WorkConcerts postponed for three weeks

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; no fever, night sweats or weight loss
RespiratoryPositiveBreathless on one flight of stairs; dry cough
CardiovascularPositiveOne spell of palpitations with light-headedness; no chest pain or fainting
EyesNegativeNo redness, pain or blurred vision
IntegumentaryNegativeNo rash, nodules or plaques
PsychiatricPositiveAnxious about singing again; PHQ-9 6; no thoughts of self-harm

6 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-23Body height170cmS
2026-02-23Body weight91.6kgS
2026-02-23Body mass index (BMI) [Ratio]31.7kg/m2S
2026-02-23Systolic blood pressure126mm[Hg]S
2026-02-23Diastolic blood pressure78mm[Hg]S
2026-02-23Heart rate82/minS
2026-02-23Respiratory rate18/minS
2026-02-23Body temperature36.7CelS
2026-02-23Oxygen saturation in Arterial blood by Pulse oximetry95%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-23FVC measured/predicted74%>=80%LowS
2026-02-23FEV1 measured/predicted76%>=80%LowS
2026-02-23FEV1/FVC80%>=70%NormalS
2026-02-23Diffusion capacity.carbon monoxide/Predicted62%>=80%LowS
2026-02-23Calcium [Mass/volume] in Serum or Plasma10.7mg/dL8.6-10.3 mg/dLHighS
2026-02-23Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.59-1.04 mg/dLNormalS
2026-02-23Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M65mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-23Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 2026-02-23; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 91.6 kg; blood pressure 126/78, pulse 82 and irregular with ectopic beats; oxygen saturation 95 percent
RespiratoryClear to auscultation; no crackles
CardiovascularOccasional ectopic beats; no murmur; no ankle swelling
SkinNo erythema nodosum, plaques or scar infiltration
Lymph nodesNo palpable cervical, axillary or inguinal nodes
PsychiatricWarm, direct, worried

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion and a dry cough for three months, worse on tour, with tiredness and chest tightness; she can no longer hold long phrases; bilateral hilar lymph node enlargement on today's chest radiograph; granulomas were reported at an abdominal operation twelve years ago, with no pathology report available: sarcoidosis must be confirmed by tissue and other causes excludedresolvedconfirmed R06.09S — Synthetic presenting problem anchored to the documented breathlessness during performances and the 1952 granulomas. Superseded by the tissue diagnosis at the consultation.
Palpitations with two spells of light-headedness while singing; ECG today: sinus rhythm with first-degree atrioventricular block (PR 240 ms) and frequent ventricular ectopic beats: cardiac involvement must be looked foractiveconfirmed R00.2S — Synthetic finding; superseded when cardiac sarcoidosis was diagnosed.
Hypercalcemia: calcium 10.8 mg/dL with a high 1,25-dihydroxyvitamin D and a low 25-hydroxyvitamin D, while taking an over-the-counter calcium and vitamin D supplement; creatinine slightly raisedactiveconfirmed E83.52S — Synthetic finding; resolved on treatment.
Pulmonary sarcoidosis with hilar and mediastinal lymph node involvement (Scadding stage II), confirmed by non-necrotizing granulomas on EBUS-guided lymph node aspiration with negative stains and cultures; mild restriction and reduced diffusing capacity; synthetic modern detail linked to her documented sarcoidosisactiveconfirmed D86.2S — Synthetic histology, stage and lung function; her biographer reports a diagnosis of sarcoidosis after granulomas were found at an operation (D, probable).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryTissue diagnosisOnce, when the diagnosis is uncertain from the clinical pictureUp to dateEBUS-guided needle aspiration rather than mediastinoscopy: non-necrotizing granulomas at three stations; no malignant cells
LaboratoryExclusion of other granulomatous causesAt diagnosisOrderedAcid-fast and fungal stains negative; mycobacterial and fungal cultures pending, final in six to eight weeks; interferon-gamma release assay and HIV negative from the first visit
ImagingSpirometry and diffusing capacity (FVC, FEV1, FEV1/FVC, DLCO)At diagnosis, three months after starting treatment, then every three to six months while treatment changesCompleted todayFVC 74 percent, FEV1 76 percent, FEV1/FVC 80 percent, DLCO 62 percent of predicted: mild restriction with reduced gas transfer
LaboratorySerum calciumAt diagnosis, then at each treatment visit while it was raised or vitamin D is givenCompleted today10.7 mg/dL off the supplement
LaboratoryKidney functionAt diagnosis, then with calcium checksCompleted todayCreatinine 1.04 mg/dL, eGFR 65
Laboratory25-hydroxyvitamin D and 1,25-dihydroxyvitamin DAt diagnosis, and before any vitamin D replacementUp to dateFrom the first visit: 25-hydroxyvitamin D 22 ng/mL (low) and 1,25-dihydroxyvitamin D 84 pg/mL (high), so vitamin D is not to be given while calcium is high
LaboratoryLiver tests, alkaline phosphatase and blood countAt diagnosisUp to dateFrom the first visit: alkaline phosphatase 128 U/L, ALT 28 U/L; lymphocytes 0.9; to be followed on treatment
ExaminationBaseline ECGAt diagnosis for every patientUp to dateFirst visit: first-degree atrioventricular block and frequent ventricular ectopy
ExaminationHolter monitoringWhen the ECG is abnormal or there are palpitationsOrderedTomorrow
ImagingEchocardiogramWhen cardiac involvement is suspectedOrderedThis week
ImagingCardiac MRI with late gadolinium enhancementWhen cardiac involvement is suspectedOrderedWithin two weeks
ImagingCardiac FDG-PETWhen cardiac involvement is suspected, before glucocorticoidsOrderedWithin two weeks, after a 72-hour high-fat, very-low-carbohydrate diet
ExaminationEye examinationAt diagnosis for every patient, then yearlyOrderedOphthalmology appointment next week
LaboratoryHepatitis B and C screeningBefore immunosuppressive treatmentOrderedHepatitis B surface antigen, core antibody and surface antibody, and hepatitis C antibody drawn today
LaboratorySerum angiotensin-converting enzymeNot used for diagnosisNot indicatedNot drawn: its sensitivity and specificity are too low to confirm or exclude sarcoidosis, and the diagnosis rests on tissue
ReferralPulmonology (sarcoidosis)At diagnosisCompleted todaySeen this morning; recommendations in the consultation note
SurveyDepression screen (PHQ-9)At diagnosis and at each phase of treatmentCompleted todayPHQ-9 6

Goal progress:

Guideline basis: Crouser ED, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020;201(8):e26-e51 (PMID 32293205) (2020); Baughman RP, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021;58(6):2004079 (PMID 34140301) (2021); Birnie DH, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11(7):1305-1323 (PMID 24819193) (2014); Cheng RK, et al. Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association. Circulation 2024;149(21):e1197-e1216 (PMID 38634276) (2024); Baughman RP, et al. Sarcoidosis in America. Analysis Based on Health Care Use. Ann Am Thorac Soc 2016;13(8):1244-1252 (PMID 27509154) (2016); Mirsaeidi M, et al. Racial difference in sarcoidosis mortality in the United States. Chest 2015;147(2):438-449 (PMID 25188873) (2015); Depression and Suicide Risk in Adults: Screening (2023)

Follow-up: Holter, echocardiogram, eye examination, cardiac MRI and FDG-PET within two weeks; review in two weeks to decide treatment. Call 911 for fainting, chest pain or a sustained racing heart. Next scheduled visit 2026-03-09: cardiac MRI and FDG-PET results: cardiac sarcoidosis; start of prednisone and methotrexate, bone and infection protection, and electrophysiology referral. [S]